Skip to main content

Bimervax emulsión FOR inyectable

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BIMERVAX EMULSION FOR INJECTION

Contents of the leaflet

  1. Introduction
  2. What is BIMERVAX and what is it used for
  3. What you need to know before you receive BIMERVAX
  4. How BIMERVAX is administered
  5. Possible side effects
  6. Storage of BIMERVAX
  7. Contents of the pack and other information

Introduction

Package Leaflet: Information for the User

BIMERVAX Injectable Emulsion

COVID-19 Vaccine (Recombinant, Adjuvanted)

selvacovateine

This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.

Read all of this leaflet carefully before you receive this vaccine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is BIMERVAX and what is it used for
  2. What you need to know before you receive BIMERVAX
  3. How BIMERVAX is administered
  4. Possible side effects
  5. Storage of BIMERVAX
  6. Contents of the pack and other information

1. What is BIMERVAX and what is it used for

BIMERVAX is a vaccine used to prevent COVID-19 caused by the SARS-CoV-2 virus.

BIMERVAX is administered to people aged 16 years and older who have previously received an mRNA vaccine against COVID-19.

The vaccine stimulates the immune system (the body's natural defenses) to produce specific antibodies that work against the virus and provide protection against COVID-19. None of the components of this vaccine can cause COVID-19.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you receive BIMERVAX

BIMERVAX must not be administered

  • if you are allergic to the active substance or to any of the other ingredients of this medicinal product (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to receive BIMERVAX if:

  • you have ever had a severe or potentially life-threatening allergic reaction after receiving any other injection of the vaccine;
  • you have ever fainted after any injection with a needle;
  • you have a high fever (over 38 °C) or a severe infection. However, you can be vaccinated if you have a mild fever or upper respiratory tract infection, such as a cold;
  • you have bleeding problems, bruise easily, or use a medicine to prevent blood clots (anticoagulant);
  • your immune system does not work properly (immunodeficiency) or you are taking medicines that weaken the immune system (such as high-dose corticosteroids, immunosuppressants, or anticancer medicines).

If you are in any of the above circumstances (or are unsure), consult your doctor, pharmacist, or nurse before receiving BIMERVAX.

As with any vaccine, BIMERVAX may not completely protect all who receive it, and it is unknown how long protection will last.

Children and adolescents

BIMERVAX is not recommended for children under 16 years of age. Currently, there is no information available on the use of BIMERVAX in children under 16 years of age.

Other medicines and BIMERVAX

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicine or vaccine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor, pharmacist, or nurse before receiving this vaccine.

Driving and using machines

Some of the side effects of BIMERVAX listed in section 4 (Possible side effects) may temporarily reduce your ability to drive and use machines. Wait until the effects of the vaccine have disappeared before driving or using machines.

BIMERVAX contains sodium, potassium, and polysorbate

This vaccine contains less than 1 mmol of sodium (23 mg) per dose; this is, essentially "sodium-free".

This vaccine contains less than 1 mmol of potassium (39 mg) per dose; this is, essentially "potassium-free".

This vaccine contains 1.18 mg of polysorbate 80 in each dose. Polysorbates may cause allergic reactions. Inform your doctor if you have any known allergy.

3. How BIMERVAX is administered

People aged 16 years and older

BIMERVAX will be administered to you as an injection of 0.5 ml into a muscle in the upper arm.

It is recommended to receive BIMERVAX in a single dose at least 6 months after a previous vaccination schedule with an mRNA vaccine against COVID-19 or after a previous booster dose of BIMERVAX.

After the injection, your doctor, pharmacist, or nurse will observe you for about 15 minutes to detect signs of an allergic reaction.

If you have any further questions about the use of BIMERVAX, ask your doctor, pharmacist, or nurse.

Immunocompromised individuals

If your immune system does not work properly, additional doses may be administered according to official recommendations.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them.

Most side effects appear within 3 days after receiving the vaccine and disappear a few days later. If symptoms persist, contact your doctor, pharmacist, or nurse.

Seek immediate medical attention if you experience symptoms of a severe allergic reaction shortly after vaccination. These symptoms may include:

  • feeling of fainting or dizziness
  • changes in heart rhythm
  • difficulty breathing
  • wheezing
  • swelling of the lips, face, or throat
  • itchy swelling under the skin (hives) or rash
  • nausea or vomiting
  • stomach pain.

The following side effects may occur with BIMERVAX:

Very common(may affect more than 1 in 10 people)

  • headache
  • pain at the injection site
  • feeling very tired (fatigue)
  • muscle pain

Common(may affect up to 1 in 10 people)

  • redness, swelling, or sensitivity at the injection site
  • feeling sick (nausea) or being sick (vomiting)
  • diarrhea
  • fever
  • enlarged lymph nodes
  • axillary pain

Uncommon(may affect up to 1 in 100 people):

  • chills or feeling of fever
  • dizziness
  • itching at the injection site
  • joint pain
  • feeling weak or lacking energy
  • feeling sleepy
  • itching of the skin
  • feeling unwell

Rare(may affect up to 1 in 1,000 people):

  • cold sweating
  • unusual feeling in the skin, such as tingling or numbness (paresthesia)
  • decreased sensitivity, especially in the skin (hypoesthesia)
  • abdominal pain
  • pain when swallowing
  • allergic reactions such as hives, skin rash, or itching
  • bruising at the injection site
  • hypersensitivity at the injection site

Frequency not known(cannot be estimated from the available data, based on a single case during clinical trials

  • inflammation of the outer lining of the heart (pericarditis), which can lead to shortness of breath, palpitations, or chest pain

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system included in Appendix V and include the batch number if available. By reporting side effects, you can help provide more information on the safety of this vaccine.

5. Storage of BIMERVAX

Keep this medicinal product out of the sight and reach of children.

Your doctor, pharmacist, or nurse is responsible for storing this vaccine and disposing of any unused product correctly. The following information on storage, expiry date, use, and handling, as well as disposal, is intended for healthcare professionals.

Do not use this vaccine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.

Store in a refrigerator (between 2 °C and 8 °C). Do not freeze. Store the vials in the outer packaging to protect them from light.

After the first puncture of the multidose vial, store between 2 °C and 8 °C and use within 6 hours.

Information on handling is described in the section for healthcare professionals at the end of the leaflet.

Disposal of the unused medicinal product and all materials that have come into contact with it should be done in accordance with local regulations.

6. Contents of the pack and other information

Composition of BIMERVAX

  • One dose (0.5 ml) contains 40 micrograms of selvacovateine with SQBA as adjuvant.
  • Selvacovateine is a fusion heterodimer with a receptor-binding domain (RBD) of the spike (S) protein of the SARS-CoV-2 virus (strains B.1.351 and B.1.1.7) produced by recombinant DNA technology.
  • SQBA is included in this vaccine as an adjuvant to accelerate and enhance the protective effects of the vaccine. SQBA contains per 0.5 ml dose: squalene (9.75 mg), polysorbate 80 (1.18 mg), sorbitan trioleate (1.18 mg), sodium citrate (0.66 mg), citric acid (0.04 mg), and water for injections.
  • The other ingredients (excipients) are: disodium phosphate dodecahydrate, potassium dihydrogen phosphate, sodium chloride, potassium chloride, and water for injections. BIMERVAX contains potassium, sodium, and polysorbate (see section 2).

Appearance and packaging

The vaccine is a homogeneous white injectable emulsion.

Multidose vial

5 ml of emulsion are supplied in a vial with a rubber stopper and a removable plastic cap.

Each multidose vial contains 10 doses of 0.5 ml.

Pack size: 10 multidose vials.

Single-dose vial

0.5 ml of emulsion are supplied in a vial with a rubber stopper and a removable plastic cap.

Each single-dose vial contains 1 dose of 0.5 ml.

Pack sizes: 5, 10, or 20 single-dose vials.

Not all pack sizes may be marketed.

Marketing authorisation holder

Hipra Human Health, S.L.U.

Avda. la Selva, 135

17170 Amer (Girona)

SPAIN

Manufacturer

Laboratorios Hipra, S.A.

Avda. la Selva, 135

17170 Amer (Girona)

SPAIN

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu

Scan the code with a mobile device to get the leaflet in different languages.

QR code to be included

Or visit the URL: www.hipracovidvaccine.com

The leaflet can be found on the European Medicines Agency website in all languages of the European Union/European Economic Area.

-------------------------------------------------------------------------------------------------------------------------

This information is intended for healthcare professionals only:

Administer BIMERVAX by intramuscular route, preferably in the deltoid muscle of the upper arm.

Traceability

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

Instructions for handling and administration

Do not use this vaccine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.

This vaccine must be handled by a healthcare professional using aseptic techniques to ensure the sterility of each dose.

Preparation for use

  • The vaccine is ready for use.
  • The unopened vaccine should be stored between 2 °C and 8 °C and kept in the outer packaging to protect it from light.
  • Immediately before use, remove the vaccine vial from the outer packaging.
  • After the first puncture of the multidose vial, record the date and time of discard (6 hours after the first puncture) in the designated area on the vial label.

Inspect the vial

  • Gently turn the vial before each dose withdrawal, as well as between each dose withdrawal in the case of the multidose vial. Do not shake.
  • Each vial contains a homogeneous white emulsion.
  • Visually inspect the vaccine for particles or discoloration before administration. Do not administer the vaccine in the presence of either.

Administer the vaccine

  • An overfill is included in each vial to ensure that a maximum of ten (10) doses (multidose vial) or one (1) dose (single-dose vial) of 0.5 ml each can be withdrawn.
  • Discard the remaining vaccine in the single-dose vial or in the multidose vial after 10 doses have been withdrawn.
  • Each 0.5 ml dose is withdrawn with a sterile needle and a sterile syringe for administration by intramuscular injection, preferably in the deltoid muscle of the upper arm.
  • Once the vaccine is loaded into the syringe, it is stable for at least 6 hours, either under refrigeration or at room temperature (<25 °c).< li>
  • Do not mix the vaccine in the same syringe with any other vaccine or medicinal product.
  • Do not mix excess vaccine from several vials.

Discard

  • After the first puncture of the multidose vial, store the opened multidose vial between 2 °C and 8 °C for a maximum of 6 hours. Discard the vaccine if it is not used within 6 hours after the first puncture of the multidose vial.
  • Discard the remaining vaccine in the single-dose vial or in the multidose vial after 10 doses have been withdrawn.

Disposal

  • Disposal of the unused medicinal product and all materials that have come into contact with it should be done in accordance with local regulations.

Online doctors for BIMERVAX EMULSION FOR INJECTION

Discuss questions about BIMERVAX EMULSION FOR INJECTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

BIMERVAX EMULSION FOR INJECTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in BIMERVAX EMULSION FOR INJECTION is covid-19, protein subunit. This information helps identify medicines with the same composition but different brand names.

BIMERVAX EMULSION FOR INJECTION is manufactured by Hipra Human Health S.L.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Pulmonologists, Infectious disease physicians, General medicine doctors, Immunologists, Lactation medicine doctors, Intensive care physicians may assess whether BIMERVAX EMULSION FOR INJECTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, BIMERVAX EMULSION FOR INJECTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (covid-19, protein subunit) include NUVAXOVID Injectable Dispersion, NUVAXOVID JN.1 INJECTABLE DISPERSION, NUVAXOVID XBB.1.5 INJECTABLE DISPERSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media